Sunil Sonwalkar

Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study

Nicholas A. Kennedy, Graham Heap, Harry Green et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 677 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease

Aleksejs Sazonovs, Nicholas A. Kennedy, Loukas Moutsianas et al. · Gastroenterology · 2019 · 409 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study

Neil Chanchlani, Simeng Lin, Claire Bewshea et al. · ˜The œLancet. Gastroenterology & hepatology · 2024 · 123 citations · Full text

Medicine, Clinical Sciences, Immunology +17

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin et al. · Nature Communications · 2022 · 81 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

A study of indefinite for dysplasia in Barrett’s oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (α‐methylacyl‐CoA‐racemase)

Sunil Sonwalkar, Olorunda Rotimi, Nigel Scott et al. · Histopathology · 2010 · 62 citations

Medicine, Oncology, Pathology +14